微信直播

Emily Chew:老年性黄斑退化症研究的最新进展

Published at: 2015年第1卷第S1期

叶伊倩
关键词:

编者按:中山大学中山眼科中心附属眼科医院50周年系列讲座——中山眼底内科与流行病学论坛于2016年6月17-18日在广州成功举行。来自National Eye Institute (NEI)的Emily Chew教授就Age-related Eye Disease Study 2的相关情况和最新进展进行了精彩的演讲。会后,Emily Y. Chew教授接受了AME的采访。在采访中,她向我们介绍了Age-related Eye Disease Study 2这个研究项目,并分享了在研究中所遇到的挑战。

采访问题:

  1. Could you give us a brief introduction of your presentation?

  2. What has been the biggest challenge in the Age-Related Eye Disease Study 2?

  3. Could you briefly introduce the large clinical trial called the Actions to Control Cardiovascular Risk in Diabetes?

  4. What is the biggest accomplishment in your career?

  5. Any suggestions for young doctors?

访谈视频:


 

专家简介:

Emily Y. Chew, M.D. is the deputy director of the Division of Epidemiology and Clinical Applications and the deputy clinical director at the National Eye Institute (NEI), National Institutes of Health (NIH). Dr. Chew has a strong clinical and research interest in diabetic eye disease and age-related eye diseases. She has thoroughly worked on analyzing the data from the Early Treatment Diabetic Retinopathy Study (ETDRS) and she continues to manage and analyze data from the Age-Related Eye Disease Study (AREDS). In addition, she is working on a large clinical trial called the Actions to Control Cardiovascular Risk in Diabetes (ACCORD).

 

采访编辑:叶伊倩,科学编辑,AME出版社;

视频编辑:麦雪芳,视频编辑,AME出版社。

doi: 10.3978/kysj.2014.1.1980

comments powered by Disqus

附件